Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$120.62 - $141.12 $31,361 - $36,691
260 Added 1.46%
18,045 $2.49 Million
Q3 2023

Nov 07, 2023

SELL
$121.86 - $144.92 $52,277 - $62,170
-429 Reduced 2.36%
17,785 $2.17 Million
Q2 2023

Aug 09, 2023

SELL
$130.56 - $146.84 $201,062 - $226,133
-1,540 Reduced 7.8%
18,214 $2.56 Million
Q1 2023

May 04, 2023

SELL
$131.53 - $155.76 $49,586 - $58,721
-377 Reduced 1.87%
19,754 $2.79 Million
Q4 2022

Feb 09, 2023

SELL
$123.31 - $157.26 $25,525 - $32,552
-207 Reduced 1.02%
20,131 $3.15 Million
Q4 2022

Feb 06, 2023

BUY
$123.31 - $157.26 $25,525 - $32,552
207 Added 1.03%
20,338 $3.18 Million
Q3 2022

Nov 07, 2022

BUY
$121.77 - $141.1 $3,531 - $4,091
29 Added 0.14%
20,131 $2.47 Million
Q2 2022

Aug 08, 2022

SELL
$127.07 - $145.39 $19,314 - $22,099
-152 Reduced 0.75%
20,102 $2.67 Million
Q1 2022

May 13, 2022

SELL
$129.09 - $164.35 $14,070 - $17,914
-109 Reduced 0.54%
20,254 $2.77 Million
Q4 2021

Feb 14, 2022

BUY
$140.36 - $173.01 $17,404 - $21,453
124 Added 0.61%
20,363 $3.52 Million
Q3 2021

Dec 08, 2021

BUY
$132.95 - $158.0 $2.69 Million - $3.2 Million
20,239 New
20,239 $2.95 Million
Q3 2021

Nov 05, 2021

SELL
$132.95 - $158.0 $1.96 Million - $2.33 Million
-14,717 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$126.66 - $141.48 $1.86 Million - $2.08 Million
14,717 New
14,717 $1.94 Million
Q3 2017

Nov 16, 2017

SELL
$91.96 - $108.35 $183,460 - $216,158
-1,995 Closed
0 $0
Q2 2017

Aug 15, 2017

BUY
N/A
1,995
1,995 $222,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.